Scintimammography

 

#Scintimammography uses small amounts of radioactive materials called radiotracers, a special camera and a computer to help investigate an abnormality discovered on mammography. Its ability to detect cancer is not limited by dense breast tissue or breast implants, and it can reduce unnecessary procedures by helping determine whether an abnormality requires biopsy.

 Learn More from the #experts in #BreastCancer2018 conference scheduled on #October 15-16,2018
at  #Rome, Italy

drop your query at- breastcancer@pulsusmeet.org / breastcancer@pulsusevents.org

follow the link for more details- https://breastcancer.pulsusconference.com/

 

Magnetic Resonance Imaging (MRI) - Breast

 

Magnetic resonance imaging (MRI) of the breast uses a powerful magnetic field, radio waves and a computer to produce detailed pictures of the structures within the breast. It is primarily used as a supplemental tool to breast screening with mammography or ultrasound. It may be used to screen women at high risk for breast cancer, evaluate the extent of cancer following diagnosis, or further evaluate abnormalities seen on mammography. Breast MRI does not use ionizing radiation, and it is the best method for determining whether silicone breast implants have ruptured.

know more about the #MRI of Breast from #Experts through the #Breast Cancer 2018 #conference
at Rome, Italy on October 15- 16, 2018 
 
 Follow the link for more details- https://breastcancer.pulsusconference.com/

 drop us your query at - breastcancer@pulsusmeet.org / breastcancer@pulsusevents.org

Breast Cancer Screening

An annual MRI screening in addition to mammography for women who have very dense breasts or have a higher-than-average risk for breast cancer. But many women apparently don’t want to have MRIs, even though the test is non-invasive and is usually paid for by insurance when recommended by a woman’s physician.
A recent study of 1,215 women turned up some surprising results among women who were eligible for no-cost breast MRIs after routine mammography and ultrasound: 42% refused the 30-minute imaging tests. A quarter of the study participants said they found the closed MRI tubes too claustrophobic (“open” MRI machines cause less anxiety for many people, but do not provide optimal breast imaging), while another 20% said having an MRI was inconvenient, requiring too much additional time and travel. While the refusals weren’t totally unexpected, the large numbers of women who balked at having MRIs surprised study authors and physicians.

 

Learn more about the #BreastCancer #Screening  from the #experts and #Researcher around the #Globe  with  #BreastCancer2018 #Conference on #October 15-16,2018 @ Rome, Italy

for more details visit our site-https://breastcancer.pulsusconference.com/

for any query drop us a mail at- breastcancer@pulsusmeet.org  / breastcancer@pulsusevents.org

Statics of Breast Cancer

• In 2018, an estimated 266,120 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 63,960 new cases of non-invasive (in situ) breast cancer.
• About 2,550 new cases of invasive breast cancer are expected to be diagnosed in men in 2018. A man’s lifetime risk of breast cancer is about 1 in 1,000.
• Breast cancer incidence rates in the U.S. began decreasing in the year 2000, after increasing for the previous two decades. They dropped by 7% from 2002 to 2003 alone. One theory is that this decrease was partially due to the reduced use of hormone replacement therapy (HRT) by women after the results of a large study called the Women’s Health Initiative were published in 2002. These results suggested a connection between HRT and increased breast cancer risk.
•  About 40,920 women in the U.S. are expected to die in 2018 from breast cancer, though death rates have been decreasing since 1989. Women under 50 have experienced larger decreases. These decreases are thought to be the result of treatment advances, earlier detection through screening, and increased awareness.

To know more be a part of our #BreastCancer 2018 Conference on #October 15-16, 2018 #Rome, Italy. 

for any query drop us an email at- breastcancer@pulsusmeet.org

#Survival  rates for breast cancer vary worldwide,but in general rates have improved. This is because #breast cancer is #diagnosed at an earlier and localised #stage in nations where populations have access to medical care, and #progressive improvement in treatment strategies.

for more details join us at #WorldCongressOnBreastCancer2018 #share your# research
for more details visit the site- https://breastcancer.pulsusconference.com/

Risk Assessments

one in every eight women will develop breast cancer in her lifetime. Despite the advances made in treating breast cancer, the causal mechanisms underlying this disease have yet to be fully elucidated; 85% of breast cancer cases occur sporadically without any known genetic mutation. Too little is known about the pathogenesis of breast cancer for primary prevention to be feasible in the near- to mid-term. Secondary prevention through screening offers an alternative that has been widely adopted. For decades, breast self-examination has been touted as a technique for the early identification of breast cancer. However, it has been recently suggested that this technique is a waste of time and resources for both doctors and patients. Mammography finds breast cancer earlier than breast self-examination, and will reduce the risk of death from breast cancer by approximately 30% in women over 50 years old. Mammography is limited in that cancer, like breast tissue, appears white on the x-ray; therefore lesions may be difficult to detect in women with very dense breasts, and a tumor may not cast a significant shadow until it is quite large. Some cancers are so aggressive that they can spread quickly, before routine screening can detect them.

#Learn more from expert by joining us at #BreastCancer2018 #conference
abstract submission link-https://bit.ly/2IaExiN
Registration link-https://bit.ly/2s5WVDn
 visit the site for more details-https://breastcancer.pulsusconference.com/

Modified citrus pectin is thought to be useful in the prevention and treatment of metastatic cancer, especially in solid tumors like melanoma and cancers of the prostate, colon, and #Breast. Scientists believe that MCP works by inhibiting two key processes involved in cancer progression: angiogenesis and metastasis.

Angiogenesis is the process in which cancer cells establish their own blood supply to fuel their growth. Metastasis occurs when cancer cells break away from the original tumor, enter the bloodstream or lymphatic system, and form a new tumor in a different organ or other parts of the body.8 Secondary or metastatic cancers often pose more life-threatening circumstances than the original tumor.
A growing number of small studies in humans and animals have reported that MCP interferes with the cancer cell’s interactions with other cancer cells by acting as a galectin-3 antagonist—that is, an agent that blocks the normal activity of galectins.

#contribute your #research to our upcoming #conference on #BreastCancer2018
scheduled on #october15-16,2018 at #Rome,Italy
 This  is a platform to innovate your research in field of #Cancer
 follow the link for more details- https://breastcancer.pulsusconference.com/
OR drop us your query at-breastcancer@pulsusevents.org

Explore your #research with #BreastCancer2018 conference which is scheduled on #October 15-16,2018. this is an opportunity for all the #researcher #Exhibitors #Students #Society for more details visit at-https://bit.ly/2s8xD6O

#Breast Cancer 2018 #track-05 #call for an abstract
Abstract submission link- https://bit.ly/2IaExiN
for more details visits-https://breastcancer.pulsusconference.com/

we welcome our new Organizing Committee Member who associate with #Breast Cancer2018# conference..Take an opportunity to be a Part of this Conference by submitting an abstract and avail early bird discount on registeration. link has been given below-
https://bit.ly/2IaExiN 
registration link- https://bit.ly/2s5WVDn 

We delightedly welcomes you  all who wanted associate with #WorldCongressonBreastCancer2018. Submit an abstract for the session of your interest and do register  for the conference to avail discount on registration. visit the link for  registration- https://bit.ly/2s5WVDn for query drop us an email at - breastcancer@pulsusevents.org scientific session link-https://bit.ly/2G6s7GY

Poster presentation

Meet our #StudentAmbassador# at World Congress on#BreastCancer#October 15-16, 2018 at Rome, Italy.. #PosterPresentation# special #discount on group registration for any query mail us at- breastcancer@pulsusevents.org  

#early bird registration is open till June 25, 2018. Don't miss the opportunity..

#WorldCongressOnBreastCancer2018# is a great opportunity to present your work and expertise platform#sSaveTheDates#SubmitAnAbstracts#MeetExpertToGlobalizeYourWork#https://bit.ly/2IaExiN

Collaborator, exhibitor and Sponsorship

#BreastCancer2018 Conference# looking for the Collaborator, exhibitor and Sponsorship..we delightedly welcome all who wanted to associate with #BreastCancer2018Conference#.. For more details follow the link - https://bit.ly/2jTTRWw https://bit.ly/2wDKdAC #WorldCongressonBreastCancer2018#BreastCancerTreatment#